BVIBE- lidocaine hcl delay spray liquid

BVibe by

Drug Labeling and Warnings

BVibe by is a Otc medication manufactured, distributed, or labeled by Private Label Productions LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingredient(s)

Lidocaine HCl 9.94 mg

Purpose

Male Genital Desensitizer Topical Anesthetic

Use

Temporarily slows ejaculation onset for premature ejaculation management.

Warnings

For external use only.
Allergy alert: Avoid if allergic to lidocaine or other topical anesthetics.
Do Not Use: On broken/irritated/sensitive skin or if partner is pregnant.
When Using: Avoid eye contact; rinse if occurs.
Do not apply excessively to avoid side effects (e.g., numbness, irregular heartbeat).
Discontinue if rash, irritation, or burning occurs.
Stop Use and Consult a Doctor If: No relief, rash, irritation, or excessive numbness occurs.
Ask a Doctor Before Use If: You have liver/kidney issues or take interacting medications.
Keep Out of Reach of Children: Contact Poison Control if swallowed.
Other Warnings: Lidocaine may numb partner's mouth/throat during oral sex; allow 10 minutes absorption or wipe excess.
Overuse (>10 sprays) may cause numbness or erection loss.

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of childeren.Contact Poison Control if

Directions

Adults: Apply 3-10 sprays to penis head/shaft (focus on frenulum/tip) 10 minutes before intercourse.
Start with 3 sprays to assess sensitivity.
Shake bottle, spray directly or massage on.
Allow 10 minutes absorption; wipe excess before oral sex.
Wash off post-intercourse.

Store at 68°-77°F, away from heat/sunlight.

Other information

Inactive ingredients

Purified Water, Propanediol, Alcohol, Aloe Barbadensis Leaf Juice, Laureth 9, PEG 8, Panthenol, Panax Ginseng Root Extract, Hydroxyethy|cellulose, Menthyl Lactate, PPG-26-Buteth-26, PEG-40 Hydrogenated Castor Oil, Caprylyl Glycol, Phenoxyethanol, Ethylhexylglycerin

Package Label - Principal Display Panel

INGREDIENTS AND APPEARANCE

BVIBE 
lidocaine hcl delay spray liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 77632-162
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987)	LIDOCAINE HYDROCHLORIDE ANHYDROUS	9.94 mg  in 0.1 mL

Inactive Ingredients
Ingredient Name	Strength
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
ALOE BARBADENSIS LEAF JUICE (UNII: RUE8E6T4NB)
WATER (UNII: 059QF0KO0R)
HYDROXYETHYLCELLULOSE (UNII: T4V6TWG28D)
PEG-8 (UNII: B697894SGQ)
METHYL LACTATE (UNII: 0379G9C44S)
DECETH-7 (UNII: 4E11OV844J)
PROPANEDIOL (UNII: 5965N8W85T)
ASIAN GINSENG (UNII: CUQ3A77YXI)
PANTOTHENIC ACID (UNII: 19F5HK2737)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALCOHOL (UNII: 3K9958V90M)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 77632-162-11	59 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product	07/15/2025

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M017	07/15/2025

Labeler - Private Label Productions LLC (046278265)